Ugro Capital (UGROCAP)

Turnaround

FairStock Score: 40/100 — MIXED

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹93.34
Market Cap₹1,426.38 Cr
P/E Ratio6.53
ROCE11.05%
ROE6.35%
Dividend Yield0%
Profit Growth33.7%
Debt/Equity3.74
Sales Growth6.7%
Promoter Holding1.7%
52-Week Range₹80.12 — ₹192.5
SectorFinance
Book Value₹190.17

Strengths

Concerns

AI Analysis

Looking at Ugro Capital, my first reaction is caution. This is an NBFC, so the balance sheet is the business. The balance sheet shows a debt-to-equity of 3.75 and return on equity of just 6.35%. That combination is not attractive: high leverage should magnify returns, but equity here is earning a weak return. The latest quarter makes the pain visible: ₹409 crore of sales produced just ₹6 crore of net profit. That is a thin margin, and the year-on-year profit decline of 82.99% confirms serious deterioration. A P/E of 13.86 may look reasonable, but I do not pay a multiple for depressed earnings without evidence of recovery. The stock trades at ₹107.92, below book value of ₹126.27, a price-to-book of 0.85. Graham liked a margin of safety, but book value in a leveraged lender can disappear when loans go bad. With a Piotroski F-score of 4/9, financial health is shaky. There is no dividend, so the only return depends on price recovery. More troubling, promoter holding is just 1.70%. I want owners with skin in the game; this is almost an orphan. On the positive side, sales are still growing 10.17%, and ROCE of 11.05% suggests the operating capital is not idle. The franchise may be lending, but profitability has collapsed. This is a potential turnaround or a value trap; the numbers do not yet tell me which. I would wait for higher margins, stable earnings, and meaningful promoter ownership before deploying capital. In Buffett's terms, this is in the too-hard pile for now.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer